David Lindholm

ID physician, medical educator. @USUhealthsci alum/faculty. Opinions are my own.

[Andre Kalil, MD MPH @DrAndreKalil]

“Baricitinib treatment is associated with a 50% reduction of secondary infections in patients hospitalized for #COVID19”

Daniel Sweeney, @camwolfe, myself, and our colleagues from ACTT-2 trial just published today these new findings:
👇Free Access
https://t.co/cA0acRvoaO

[David Lindholm @DavidALindholm]

@TWellington51 @pwhickey @USUhealthsci Our study of arboviral infections in the MHS was recently published in @AJTMH

[Arbovirus News @ArboNews]

The Burden of Arboviral Infections in the Military Health System 2012-2019
https://t.co/I4IguMkGdA

[Temple Ratcliffe, MD, MS-HPEd @templeratcliffe]

Amazing energy at “Feedback for Faculty Feedback” earlier today at #AIMW23 — love learning with and from our @AAIMOnline community!

*Handouts now available on the app 😃

[David Lye @davidlye70]

Patient characteristics explained improved outcomes from ACTT1 to ACTT2 but not from ACTT2 to ACTT3, suggesting better standard of care. This raises concern on using historical controls in large platform trials. #ACTT #COVID19 #NIH
https://t.co/CHnZt12bLa

[Annals of Int Med @AnnalsofIM]

Study of standard-of-care #COVID19 measures found improvements in recovery and mortality over time in adults hospitalized with COVID-19: https://t.co/5uFoLKCi3c @NIH

[Vince Marconi @vmarconi2]

Sadly this disease is already off the radar - I see this happening with Long COVID too. Ebola is growing in Uganda with hardly a word here in the U.S. We really need to have more lasting approaches to these emerging diseases even when they are not hot in the media.

[The Lancet Infectious Diseases @TheLancetInfDis]

New personal view: Déjà vu all over again? Monkeypox and the urgent need for randomised controlled trials
https://t.co/AxtuKbRjFl

[David Lindholm @DavidALindholm]

Thanks for collaborating @DrAndreKalil!

@USUhealthsci @BrookeArmyMed @TheLancetInfDis @SAUSHECIMRes

[Andre Kalil, MD MPH @DrAndreKalil]

"Déjà vu all over again? #Monkeypox and the urgent need for randomised controlled trials"

@DavidALindholm and I wrote this new article just out in Lancet.

#MedTwitter #IDTwitter @UNMC_ID @IDSAInfo @ESCMID @Boghuma @CarlosdelRio7 @PaulSaxMD @EricTopol
👇
https://t.co/DiQ3x1X4I1

[william kelly @williamkellymd]

Can't wait for #TriserviceACP next week! So many amazing sessions over 3 days-- and stop by Wednesday at 1030 to talk frameworks for making evaluations fair and EASIER (Milestones, EPAs, RIME) with us @ACPinternists @army_acp @AcpNavy @AirForce_ACP @USUhealthsci @DavidALindholm

[Andre Kalil, MD MPH @DrAndreKalil]

💥Just Out
ACTT-4 Trial👉First Double Placebo-Controlled Double-Blind Randomized-Stratified Head-to-Head
#DEXAMETHASONE vs #BARICITINIB for hospitalized pts w/#COVID19 Low/High-Flow/NIV
Relevant👉Patient Care/Public Health/Guidelines
Our results
👇
https://t.co/4Tmue7HK7V
🧵1/4

[Andre Kalil, MD MPH @DrAndreKalil]

💥HISTORIC DAY FOR MEDICINE:
First immunomodulatory Tx ever approved for an acute infection!
👇
FDA approves the first immunomodulatory Tx for #COVID19→https://t.co/q31KJV6pGw
#BARICITINIB→⬇️Death⬇️Intubation⬆️Recovery
👇
https://t.co/cqfzk1bxkR
https://t.co/UnbinXsrzH
🧵1/

[Andre Kalil, MD MPH @DrAndreKalil]

@SCCM @ESICM #MedTwitter #IDTwitter #TxID @AST_IDCOP @IDJClub #TwitteRx #MedEd @PulmCrit @IM_Crit_ @PulmCCM @SolNataMD @thanh_neville @nickmmark @gbosslet @WesElyMD @MSharifpourMD @chungk1031 @drjacky_fit @laxswami @PaulSaxMD @ABsteward @vmarconi2 @UNMC_ID @UNMC_IM @UNMC_PCCM

[Andre Kalil, MD MPH @DrAndreKalil]

#Remdesivir new trial just published

Here are the clinical implications:
Canadian trial (CATCO) in hospitalized patients with #COVID19 https://t.co/WRyg8W8fkU
Compared to ACTT-1 trial https://t.co/rDofR4mlbP in patients on supplemental O2 as recommended by guidelines
🧵1/

[Kevin K. Chung, MD @chungk1031]

Awesome work by @colombocj1 et al.

Performance Analysis of the National Early Warning Score... : Critical Care Explorations https://t.co/hoJwmq7LQ8

[william kelly @williamkellymd]

Some of the background on RIME in case you missed it!
VIDEO: https://t.co/Qq8TKk6J24

[william kelly @williamkellymd]

Do you assess learners? You KNOW you do. Is it fair? There’s a framework for that! Join our discussion of #EPAs and RIME at 2:15 EST #aaimonline21 #410 @AAIMOnline @USUhealthsci

[David Lindholm @DavidALindholm]

@YunHeather @jenhsuID @BonuraErin @joshuadhartzell @ArtKellermannMD @CarlosdelRio7 @DocWoc71 @josh_nosanchuk @Armstrws @DrJeanneM @VidhyaPrakashIL @BSchwartzinSF @dr_c_cable @IDSAMedEdCOP

[David Lindholm @DavidALindholm]

Impact of COVID-19 on medical career choice? Survey link below for students/IM residents @chungk1031 @williamkellymd @good_morrow78 @joshuadhartzell @jen_babik @aoglasser @USUhealthsci @templeratcliffe

[David Lindholm @DavidALindholm]

Thrilled to get the #COVIDVaccine today. My medicine ward team took a break from rounds to get it.